Gesellschaft für Therapieforschung mbH

A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes

Role: collaborator

Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting

Role: collaborator

Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients with Mild to Moderately Active Ulcerative Colitis

Role: collaborator

TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma Patients

Role: collaborator

5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis

Role: collaborator

A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes

Role: collaborator

Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood

Role: collaborator

Treatment of Actinic Keratosis With 5% KOH Solution

Role: collaborator

An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients

Role: collaborator

An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis

Role: collaborator

A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone

Role: collaborator